Hypermenorrhoea and dysmenorrhoea were significantly higher (P = 0.0001 and P < 0.0001, respectively; Table 1) in the AM group than in the control group, and AM patients exhibited higher CA125 levels (P < 0.0001; Table 1). This evidence concerns the gene MUC16 and Dysmenorrhea.